168 related articles for article (PubMed ID: 24242937)
1. MDR1 and OAT1/OAT3 mediate the drug-drug interaction between puerarin and methotrexate.
Liu Q; Wang C; Meng Q; Huo X; Sun H; Peng J; Ma X; Sun P; Liu K
Pharm Res; 2014 May; 31(5):1120-32. PubMed ID: 24242937
[TBL] [Abstract][Full Text] [Related]
2. P-gp, MRP2 and OAT1/OAT3 mediate the drug-drug interaction between resveratrol and methotrexate.
Jia Y; Liu Z; Wang C; Meng Q; Huo X; Liu Q; Sun H; Sun P; Yang X; Ma X; Liu K
Toxicol Appl Pharmacol; 2016 Sep; 306():27-35. PubMed ID: 27377006
[TBL] [Abstract][Full Text] [Related]
3. Puerarin improves methotrexate-induced renal damage by up-regulating renal expression of Oat1 and Oat3 in vivo and in vitro.
Liu Q; Liu Z; Huo X; Wang C; Meng Q; Sun H; Sun P; Peng J; Ma X; Liu K
Biomed Pharmacother; 2018 Jul; 103():915-922. PubMed ID: 29710508
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Methotrexate Uptake via Organic Anion Transporters OAT1 and OAT3 by Glucuronides of Nonsteroidal Anti-inflammatory Drugs.
Iwaki M; Shimada H; Irino Y; Take M; Egashira S
Biol Pharm Bull; 2017; 40(6):926-931. PubMed ID: 28566636
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate-bestatin interaction: involvement of P-glycoprotein and organic anion transporters in rats.
Zhu Y; Meng Q; Wang C; Liu Q; Huo X; Zhang A; Sun P; Sun H; Li H; Liu K
Int J Pharm; 2014 Apr; 465(1-2):368-77. PubMed ID: 24530518
[TBL] [Abstract][Full Text] [Related]
6. Effect of methotrexate treatment on expression levels of multidrug resistance protein 2, breast cancer resistance protein and organic anion transporters Oat1, Oat2 and Oat3 in rats.
Shibayama Y; Ushinohama K; Ikeda R; Yoshikawa Y; Motoya T; Takeda Y; Yamada K
Cancer Sci; 2006 Nov; 97(11):1260-6. PubMed ID: 16925582
[TBL] [Abstract][Full Text] [Related]
7. Interaction of immunosuppressive drugs with human organic anion transporter (OAT) 1 and OAT3, and multidrug resistance-associated protein (MRP) 2 and MRP4.
El-Sheikh AA; Greupink R; Wortelboer HM; van den Heuvel JJ; Schreurs M; Koenderink JB; Masereeuw R; Russel FG
Transl Res; 2013 Dec; 162(6):398-409. PubMed ID: 24036158
[TBL] [Abstract][Full Text] [Related]
8. The key role of organic anion transporter 3 in the drug-drug interaction between tranilast and methotrexate.
Wang J; Yuan W; Shen Q; Wu Q; Jiang Z; Wu W; Zhang L; Huang X
J Biochem Mol Toxicol; 2022 Apr; 36(4):e22983. PubMed ID: 35019195
[TBL] [Abstract][Full Text] [Related]
9. PEPT1- and OAT1/3-mediated drug-drug interactions between bestatin and cefixime in vivo and in vitro in rats, and in vitro in human.
Wang L; Wang C; Liu Q; Meng Q; Huo X; Sun P; Yang X; Sun H; Zhen Y; Peng J; Ma X; Liu K
Eur J Pharm Sci; 2014 Oct; 63():77-86. PubMed ID: 25016073
[TBL] [Abstract][Full Text] [Related]
10. Coadministration of vindesine with high-dose methotrexate therapy increases acute kidney injury via BCRP, MRP2, and OAT1/OAT3.
Huang C; Xia F; Xue L; Liu L; Bian Y; Jin Z; Miao L
Cancer Chemother Pharmacol; 2020 Feb; 85(2):433-441. PubMed ID: 31691080
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of valsartan on the intestinal absorption and renal excretion of bestatin in rats.
Huo X; Liu Q; Wang C; Meng Q; Sun H; Peng J; Ma X; Sun P; Liu K
J Pharm Sci; 2014 Feb; 103(2):719-29. PubMed ID: 24338900
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of possible pharmacokinetic interaction between methotrexate and proton pump inhibitors in rats.
Ueda H; Narumi K; Sato Y; Furugen A; Kobayashi M; Iseki K
Pharmacol Rep; 2020 Oct; 72(5):1426-1432. PubMed ID: 32671657
[TBL] [Abstract][Full Text] [Related]
13. Proton pump inhibitors inhibit methotrexate transport by renal basolateral organic anion transporter hOAT3.
Chioukh R; Noel-Hudson MS; Ribes S; Fournier N; Becquemont L; Verstuyft C
Drug Metab Dispos; 2014 Dec; 42(12):2041-8. PubMed ID: 25239859
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of JBP485 on renal excretion of acyclovir by the inhibition of OAT1 and OAT3.
Ye J; Liu Q; Wang C; Meng Q; Peng J; Sun H; Kaku T; Liu K
Eur J Pharm Sci; 2012 Sep; 47(2):341-6. PubMed ID: 22728397
[TBL] [Abstract][Full Text] [Related]
15. Activation of protein kinase Czeta increases OAT1 (SLC22A6)- and OAT3 (SLC22A8)-mediated transport.
Barros SA; Srimaroeng C; Perry JL; Walden R; Dembla-Rajpal N; Sweet DH; Pritchard JB
J Biol Chem; 2009 Jan; 284(5):2672-2679. PubMed ID: 19028678
[TBL] [Abstract][Full Text] [Related]
16. OAT1 and OAT3: targets of drug-drug interaction between entecavir and JBP485.
Xu Q; Wang C; Meng Q; Liu Q; Sun H; Peng J; Ma X; Kaku T; Liu K
Eur J Pharm Sci; 2013 Mar; 48(4-5):650-7. PubMed ID: 23313623
[TBL] [Abstract][Full Text] [Related]
17. OAT1 and OAT3 also mediate the drug-drug interaction between piperacillin and tazobactam.
Wen S; Wang C; Duan Y; Huo X; Meng Q; Liu Z; Yang S; Zhu Y; Sun H; Ma X; Yang S; Liu K
Int J Pharm; 2018 Feb; 537(1-2):172-182. PubMed ID: 29277663
[TBL] [Abstract][Full Text] [Related]
18. Renal expression and function of oat1 and oat3 in rats with vascular calcification.
Bulacio R; Hazelhoff MH; Torres AM
Pharmacology; 2012; 90(1-2):66-77. PubMed ID: 22759781
[TBL] [Abstract][Full Text] [Related]
19. Quantitative evaluation of the drug-drug interactions between methotrexate and nonsteroidal anti-inflammatory drugs in the renal uptake process based on the contribution of organic anion transporters and reduced folate carrier.
Nozaki Y; Kusuhara H; Endou H; Sugiyama Y
J Pharmacol Exp Ther; 2004 Apr; 309(1):226-34. PubMed ID: 14722319
[TBL] [Abstract][Full Text] [Related]
20. Influence of organic anion transporter 1/3 on the pharmacokinetics and renal excretion of ginkgolides and bilobalide.
Yaro P; Nie J; Xu M; Zeng K; He H; Yao J; Wang R; Zeng S
J Ethnopharmacol; 2019 Oct; 243():112098. PubMed ID: 31325605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]